Nxera Pharma Co., Ltd. (FRA:JSS)

Nxera Pharma Revenue

Nxera Pharma had revenue of 6.75B JPY in the quarter ending September 30, 2025, a decrease of -27.09%. This brings the company's revenue in the last twelve months to 28.70B, down -1.96% year-over-year. In the year 2024, Nxera Pharma had annual revenue of 28.84B with 125.87% growth.

• Revenue (ttm): 28.70B JPY
• Revenue Growth: -1.96%
• P/S Ratio: 2.42
• Revenue / Employee: 74.74M JPY
• Employees: 384
• Market Cap: 400.76M EUR

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.84B	16.07B	125.87%
Dec 31, 2023	12.77B	-2.80B	-18.00%
Dec 31, 2022	15.57B	-2.14B	-12.10%
Dec 31, 2021	17.71B	8.87B	100.32%
Dec 31, 2020	8.84B	-884.00M	-9.09%